Ocado is adapting its advanced food filling technology for pharmaceutical warehouses. The goal is to make progress in pharmaceutical product fulfillment by 2026. The article questions whether current software can handle these challenges. In the pharmaceutical industry, strategic deals in biopharma are expected to accelerate in 2026 due to the interplay of innovation and stability[1]. Firms such as Eli Lilly are implementing 24/7 continuous production, which reduces downtime and waste, but increases risks such as equipment failure or contamination[2]. By the end of 2026, the Drug Supply Chain Security Act requires full serialization and traceability in the drug supply chain[2]. Many companies are moving production closer to home, which reduces geopolitical risks but increases regulatory complexity[2]. The average cost of bringing a new drug to market exceeds $2 billion, highlighting the priority of improving R&D productivity[3].